How has the field of immunogenic cell death in breast cancer evolved and impacted clinical practice over the past eleven years?
This study elucidates the research landscape of immunogenic cell death (ICD) in breast cancer through a bibliometric analysis of 457 Web of Science articles. Contributions from China and the USA are particularly prominent, with notable international collaborations. Core journals such as Biomaterials...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2025.2505349 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849325736858484736 |
|---|---|
| author | Yu-Long Deng Bang-Teng Chi Shang-Yi Lu Dan-Dan Xiong Rong-Quan He Di-Yuan Qin Wan-Ying Huang Xia Yang Gang Chen Wei Peng Jiayuan Luo |
| author_facet | Yu-Long Deng Bang-Teng Chi Shang-Yi Lu Dan-Dan Xiong Rong-Quan He Di-Yuan Qin Wan-Ying Huang Xia Yang Gang Chen Wei Peng Jiayuan Luo |
| author_sort | Yu-Long Deng |
| collection | DOAJ |
| description | This study elucidates the research landscape of immunogenic cell death (ICD) in breast cancer through a bibliometric analysis of 457 Web of Science articles. Contributions from China and the USA are particularly prominent, with notable international collaborations. Core journals such as Biomaterials published influential studies, while researchers like Huang Y made impactful contributions. High-frequency keyword analysis identified key research hotspots, including immunotherapy, the tumor microenvironment, and nanomedicine. The integration of chemotherapy with immunotherapy and the identification of key proteins have driven recent advancements. Fundamental research on immunotherapy, photodynamic therapy (PDT), and triple-negative breast cancer (TNBC) points to future trends and potential breakthroughs. This study offers a strategic overview of ICD in breast cancer, providing insights into clinical practice and guiding future research in the field. |
| format | Article |
| id | doaj-art-8e5843a18ffe4d7abceec4b8b2952b5c |
| institution | Kabale University |
| issn | 2164-5515 2164-554X |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj-art-8e5843a18ffe4d7abceec4b8b2952b5c2025-08-20T03:48:19ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2025-12-0121110.1080/21645515.2025.2505349How has the field of immunogenic cell death in breast cancer evolved and impacted clinical practice over the past eleven years?Yu-Long Deng0Bang-Teng Chi1Shang-Yi Lu2Dan-Dan Xiong3Rong-Quan He4Di-Yuan Qin5Wan-Ying Huang6Xia Yang7Gang Chen8Wei Peng9Jiayuan Luo10Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. ChinaDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. ChinaDepartment of Hepatological and Gland Surgery, Wuzhou Gongren Hospital/The Seventh Affiliated Hospital of Guangxi Medical University, Wuzhou, P. R. ChinaDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. ChinaDepartment of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. ChinaDepartment of Computer Science and Technology, School of Computer and Electronic Information, Guangxi University, Nanning, P. R. ChinaDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. ChinaDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. ChinaDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. ChinaDepartment of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. ChinaDepartment of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. ChinaThis study elucidates the research landscape of immunogenic cell death (ICD) in breast cancer through a bibliometric analysis of 457 Web of Science articles. Contributions from China and the USA are particularly prominent, with notable international collaborations. Core journals such as Biomaterials published influential studies, while researchers like Huang Y made impactful contributions. High-frequency keyword analysis identified key research hotspots, including immunotherapy, the tumor microenvironment, and nanomedicine. The integration of chemotherapy with immunotherapy and the identification of key proteins have driven recent advancements. Fundamental research on immunotherapy, photodynamic therapy (PDT), and triple-negative breast cancer (TNBC) points to future trends and potential breakthroughs. This study offers a strategic overview of ICD in breast cancer, providing insights into clinical practice and guiding future research in the field.https://www.tandfonline.com/doi/10.1080/21645515.2025.2505349Breast cancerimmunogenic cell deathbibliometricimmunotherapyclinical practice |
| spellingShingle | Yu-Long Deng Bang-Teng Chi Shang-Yi Lu Dan-Dan Xiong Rong-Quan He Di-Yuan Qin Wan-Ying Huang Xia Yang Gang Chen Wei Peng Jiayuan Luo How has the field of immunogenic cell death in breast cancer evolved and impacted clinical practice over the past eleven years? Human Vaccines & Immunotherapeutics Breast cancer immunogenic cell death bibliometric immunotherapy clinical practice |
| title | How has the field of immunogenic cell death in breast cancer evolved and impacted clinical practice over the past eleven years? |
| title_full | How has the field of immunogenic cell death in breast cancer evolved and impacted clinical practice over the past eleven years? |
| title_fullStr | How has the field of immunogenic cell death in breast cancer evolved and impacted clinical practice over the past eleven years? |
| title_full_unstemmed | How has the field of immunogenic cell death in breast cancer evolved and impacted clinical practice over the past eleven years? |
| title_short | How has the field of immunogenic cell death in breast cancer evolved and impacted clinical practice over the past eleven years? |
| title_sort | how has the field of immunogenic cell death in breast cancer evolved and impacted clinical practice over the past eleven years |
| topic | Breast cancer immunogenic cell death bibliometric immunotherapy clinical practice |
| url | https://www.tandfonline.com/doi/10.1080/21645515.2025.2505349 |
| work_keys_str_mv | AT yulongdeng howhasthefieldofimmunogeniccelldeathinbreastcancerevolvedandimpactedclinicalpracticeoverthepastelevenyears AT bangtengchi howhasthefieldofimmunogeniccelldeathinbreastcancerevolvedandimpactedclinicalpracticeoverthepastelevenyears AT shangyilu howhasthefieldofimmunogeniccelldeathinbreastcancerevolvedandimpactedclinicalpracticeoverthepastelevenyears AT dandanxiong howhasthefieldofimmunogeniccelldeathinbreastcancerevolvedandimpactedclinicalpracticeoverthepastelevenyears AT rongquanhe howhasthefieldofimmunogeniccelldeathinbreastcancerevolvedandimpactedclinicalpracticeoverthepastelevenyears AT diyuanqin howhasthefieldofimmunogeniccelldeathinbreastcancerevolvedandimpactedclinicalpracticeoverthepastelevenyears AT wanyinghuang howhasthefieldofimmunogeniccelldeathinbreastcancerevolvedandimpactedclinicalpracticeoverthepastelevenyears AT xiayang howhasthefieldofimmunogeniccelldeathinbreastcancerevolvedandimpactedclinicalpracticeoverthepastelevenyears AT gangchen howhasthefieldofimmunogeniccelldeathinbreastcancerevolvedandimpactedclinicalpracticeoverthepastelevenyears AT weipeng howhasthefieldofimmunogeniccelldeathinbreastcancerevolvedandimpactedclinicalpracticeoverthepastelevenyears AT jiayuanluo howhasthefieldofimmunogeniccelldeathinbreastcancerevolvedandimpactedclinicalpracticeoverthepastelevenyears |